Alcidion Group

Alcidion Group OCF/Debt

The Operating Cash Flow to Debt Ratio of Alcidion Group (ALC.AX) as of Nov 11, 2026 is 841.03 %. In the previous year, Operating Cash Flow to Debt Ratio was 410.18 % — a change of 105.04% (higher).

OCF/Debt

841.03 %

YoY

105.04%

Last updated:

Operating Cash Flow to Debt Ratio of Alcidion Group is 2026 841.03 % . Operating Cash Flow to Debt Ratio of Alcidion Group was 2025 410.18 % . It decreases by 105.04% higher compared to the previous year.

The Alcidion Group OCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF/Debt
Date
OCF/Debt
Jan 1, 2019
52.79 AUD
Jan 1, 2020
-638.65 AUD
Jan 1, 2021
853.59 AUD
Jan 1, 2022
40.10 AUD
Jan 1, 2023
7.84 AUD
Jan 1, 2024
-420.59 AUD
Jan 1, 2025
410.18 AUD
Jan 1, 2026
841.03 AUD
The Alcidion Group OCF/Debt history
YEAROCF/DebtYoY
841.03 %+105.04%
410.18 %-197.52%
-420.59 %-5,463.14%
7.84 %-80.44%
40.10 %-95.30%
853.59 %-233.66%
-638.65 %-1,309.77%
52.79 %-127.25%
-193.75 %+203.24%
-63.89 %-99.88%
-51,513.36 %+280,397.66%
-18.36 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Alcidion Group Stock analysis

What does Alcidion Group do? Alcidion Group Ltd. generates revenue through the development and licensing of its healthcare software products, including Miya Precision, Miya Observations, Flow, Task Management, and PAS, marketed under the Miya brand. The company also resells selected healthcare software from strategic partners and provides implementation, support, maintenance, and data analysis services to healthcare customers in Australia, New Zealand, and the United Kingdom. Its flagship product Miya Precision, a FHIR-event platform-based solution, supports clinical and operational applications, while Smartpage offers hospital communication and task management via smartphone and web. The firm serves over 400 hospitals across its key markets. Miya Precision and its associated modules form the core of Alcidion's product portfolio, targeting hospitals seeking integrated clinical solutions. Smartpage, Patientrack, and Silverlink PCS complement these offerings, catering to diverse healthcare communication and operational needs. The company’s revenue streams are driven by direct sales of software licenses, ongoing service contracts, and partner resales, with a focus on the Australian, New Zealand, and UK healthcare sectors. Alcidion’s business model emphasizes software licensing and service delivery, with Miya Precision as the primary revenue generator. The company’s strategic partnerships enable it to resell third-party software, expanding its product range without additional development costs. Healthcare institutions in Australia, New Zealand, and the United Kingdom are the primary buyers, leveraging Alcidion’s solutions for improved clinical workflows and operational efficiency. Alcidion Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Alcidion Group stock

Operating Cash Flow to Debt Ratio of Alcidion Group is 841.03 % in 2026.

Operating Cash Flow to Debt Ratio of Alcidion Group changed from 410.18 % to 841.03 %, representing a 105.04% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow to Debt Ratio Alcidion Group since 2006 – with annual values, charts, and detailed analysis.

OCF/Debt measures what percentage of total debt can be covered by annual operating cash flow. Higher ratios indicate stronger debt repayment capacity.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow to Debt Ratio's Alcidion Group with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Alcidion Group

All Key Metrics — Alcidion Group